Xeris Pharmaceuticals | XERS - Passivo Circulante





Passivo Circulante Alterar Data
Celltrion KRW 292.71B 9.09B 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 186K 2.26M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pharma Mar EUR 89.23M 4.65M 2026-03
Qiagen NV USD 479.11M 33.03M 2026-03
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03